<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Clinical Pharmacology News</title> 
<link>http://www.mdlinx.com/PALinx/news.cfm/newspage/1/spec_id/36/subspec_id/563</link> 
<description>Clinical Pharmacology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>









<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 



<item> 
<title><![CDATA[Severe pruritic rash, fever, and malaise]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2940803</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>The Clinical Advisor</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2940803</guid>
</item> 
 

<item> 
<title><![CDATA[The Patient Medication List: Can We Get Patients More Involved in Their Medical Care?]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2944977</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Journal of the American Board of Family Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2944977</guid>
</item> 
 

<item> 
<title><![CDATA[Clinical Importance of Purulence in Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2944973</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Journal of the American Board of Family Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2944973</guid>
</item> 
 

<item> 
<title><![CDATA[Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2944978</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Journal of the American Board of Family Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2944978</guid>
</item> 
 

<item> 
<title><![CDATA[Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2942320</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Diabetic Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2942320</guid>
</item> 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 

<item> 
<title><![CDATA[The treatment of diabetic foot infections: focus on ertapenem]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2945259</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Vascular Health and Risk Management</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2945259</guid>
</item> 
 

<item> 
<title><![CDATA[Oral Calcium Supplements Do Not Affect the Progression of Aortic Valve Calcification or Coronary Artery Calcification]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2944968</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Journal of the American Board of Family Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2944968</guid>
</item> 
 

<item> 
<title><![CDATA[Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2945206</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>American Journal of Epidemiology</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2945206</guid>
</item> 
 

<item> 
<title><![CDATA[Comparative assessment of angiotensin receptor blockers in different clinical settings]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2943279</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Vascular Health and Risk Management</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2943279</guid>
</item> 
 

<item> 
<title><![CDATA[Extrastriatal dopamine D2 receptor occupancy in olanzapine-treated patients with schizophrenia]]></title> 
<link>http://www.mdlinx.com/PALinx/xml-article.cfm/2926966</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>European Archives of Psychiatry and Clinical Neuroscience</b>]]></description> 
<guid>http://www.mdlinx.com/PALinx/xml-article.cfm/2926966</guid>
</item> 
 
 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
  


</channel> 
</rss>

